ContraVir Pharmaceuticals, Inc. Purchase Agreements
9 Contracts & Agreements
- Form of Securities Purchase Agreement (Filed With SEC on July 22, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on October 3, 2023)
- Form of Securities Purchase Agreement between Hepion Pharmaceuticals, Inc. and the investors thereto, dated November 4, 2022 (Filed With SEC on November 9, 2022)
- Amendment No. 1 to NICAMS Purchase and Sale Agreement by and between Aurinia Pharmaceuticals Inc., Ciclofilin Pharmaceuticals Inc., an Alberta Corporation and Ciclofilin... (Filed With SEC on November 12, 2020)
- NICAMS Purchase and Sale Agreement by and between Ciclofilin Pharmaceuticals Corp. and Aurinia Pharmaceuticals, Inc. dated February 14, 2014 (Filed With SEC on November 12, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on June 5, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on April 18, 2019)
- Form of Securities Purchase Agreement, dated March 13, 2019, by and among the Company and the Investor (Filed With SEC on March 19, 2019)
- Securities Purchase Agreement, dated May 8, 2018, by and between ContraVir Pharmaceuticals, Inc. and Iliad Research and Trading, L.P (Filed With SEC on May 15, 2018)
